Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Jun:14 Suppl 13:223-6.

Morbidity in systemic lupus erythematosus

D D Gladman, M B Urowitz
  • PMID: 3612650

Morbidity in systemic lupus erythematosus

D D Gladman et al. J Rheumatol Suppl. 1987 Jun.

Abstract

Over the past 30 years there has been an increase in the survival rate in systemic lupus erythematosus (SLE). As patients with SLE live longer, clinicians involved in their care are confronted with the longterm morbid complications that result either from previous SLE disease itself or as a complication of therapy. Our paper deals with the changing pattern of morbidity in SLE and specifically highlights 3 aspects: atherosclerosis, avascular necrosis and neuropsychological dysfunction. These must be considered as added features in the disease spectrum of SLE.

PubMed Disclaimer

Similar articles

  • [Myocardial infarction in systemic lupus erythematosus].
    Dëmin AA, Sentiakova TN, Ostankovich OI, Semenova LA. Dëmin AA, et al. Klin Med (Mosk). 1993;71(4):34-41. Klin Med (Mosk). 1993. PMID: 8246413 Russian.
  • Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH. Mahmoud RA, et al. Clin Biochem. 2005 Feb;38(2):134-41. doi: 10.1016/j.clinbiochem.2004.11.002. Clin Biochem. 2005. PMID: 15642275
  • Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project".
    Cervera R, Abarca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, Bacarelli MR, Bellisai F, Bernardino I, Biernat-Kaluza E, Blockmans D, Boki K, Bracci L, Campanella V, Camps MT, Carcassi C, Cattaneo R, Cauli A, Cervera R, Chwalinska-Sadowska H, Contu L, Cosyns JP, Danieli MG, DCruz D, Depresseux G, Direskeneli H, Domènech I, Espinosa G, Fernández-Nebro A, Ferrara GB, Font J, Frutos MA, Galeazzi M, Garcìa-Carrasco M, García Iglesias MF, García-Tobaruela A, George J, Gil A, González-Santos P, Grana M, Gül A, Haga HJ, de Haro-Liger M, Houssiau F, Hughes GR, Ingelmo M, Jedryka-Góral A, Khamashta MA, Lavilla P, Levi Y, López-Dulpa M, López-Soto A, Maldykowa H, Marcolongo R, Mathieu A, Morozzi G, Nicolopoulou N, Papasteriades C, Passiu G, Perelló I, Petera P, Petrovic R, Piette JC, Pintado V, de Pita O, Popovic R, Pucci G, Puddu P, de Ramón E, Ramos-Casals M, Rodríguez-Andreu J, Ruiz-Irastorza G, Sanchez-Lora J, Sanna G, Scorza R, Sebastiani GD, Sherer Y, Shoenfeld Y, Simpatico A, Sinico RA, Smolen J, Tincani A, Tokgöz G, Urbano-Márquez A, Vasconcelos C, Vázquez JJ, Veronesi J, Vianna J, Vivancos J; European Working Party on Systemic Lupus Erythematosus. Cervera R, et al. Autoimmun Rev. 2006 Mar;5(3):180-6. doi: 10.1016/j.autrev.2005.06.004. Epub 2005 Jul 26. Autoimmun Rev. 2006. PMID: 16483917 Review.
  • Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE?
    Al Attia HM. Al Attia HM. Int J Dermatol. 2006 Apr;45(4):366-9. doi: 10.1111/j.1365-4632.2006.02508.x. Int J Dermatol. 2006. PMID: 16650159
  • Vasculitis in systemic lupus erythematosis.
    Calamia KT, Balabanova M. Calamia KT, et al. Clin Dermatol. 2004 Mar-Apr;22(2):148-56. doi: 10.1016/j.clindermatol.2003.12.022. Clin Dermatol. 2004. PMID: 15234016 Review.
See all similar articles

Cited by

See all "Cited by" articles